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Abstract
Objectives: To investigate the suggested role of Porphyromonas gingivalis peptidylarginine deiminase (PAD) in the
relationship between the aetiology of periodontal disease and experimentally induced arthritis and the possible association
between these two conditions.
Methods: A genetically modified PAD-deficient strain of P. gingivalis W50 was produced. The effect of this strain, compared
to the wild type, in an established murine model for experimental periodontitis and experimental arthritis was assessed.
Experimental periodontitis was induced following oral inoculation with the PAD-deficient and wild type strains of P.
gingivalis. Experimental arthritis was induced via the collagen antibody induction process and was monitored by assessment
of paw swelling and micro-CT analysis of the radio-carpal joints. Experimental periodontitis was monitored by micro CT
scans of the mandible and histological assessment of the periodontal tissues around the mandibular molars. Serum levels of
anti-citrullinated protein antibodies (ACPA) and P. gingivalis were assessed by ELISA.
Results: The development of experimental periodontitis was significantly reduced in the presence of the PAD-deficient P.
gingivalis strain. When experimental arthritis was induced in the presence of the PAD-deficient strain there was less paw
swelling, less erosive bone damage to the joints and reduced serum ACPA levels when compared to the wild type P.
gingivalis inoculated group.
Conclusion: This study has demonstrated that a PAD-deficient strain of P. gingivalis was associated with significantly
reduced periodontal inflammation. In addition the extent of experimental arthritis was significantly reduced in animals
exposed to prior induction of periodontal disease through oral inoculation of the PAD-deficient strain versus the wild type.
This adds further evidence to the potential role for P. gingivalis and its PAD in the pathogenesis of periodontitis and
exacerbation of arthritis. Further studies are now needed to elucidate the mechanisms which drive these processes.
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Introduction
The endogenous microbes inhabiting humans often interact in
complex ways with their hosts. Changes in the local environment
can lead to qualitative and/or quantitative changes in commensal
microbial communities that, if left unchecked, can result in disease.
Chronic periodontitis is a common inflammatory condition
affecting the tissues surrounding teeth. A prolonged, uncontrolled
inflammatory response to the sub-gingival microbial load may lead
to loss of periodontal ligament attachment and the adjacent
alveolar bone [1]. In recent years periodontitis has been linked to
the development of other disorders, such as coronary heart disease,
diabetes mellitus and low birth weight [2]. While these associations
are largely based on epidemiological evidence and for most there is
currently no apparent common underlying cause, dysregulation of
the inflammatory response seems to be a common underlying
feature [3]. Two of the most prevalent chronic inflammatory
conditions affecting humans that share many common features,
including destruction of both fibrous connective tissue and bone,
osteoclast activation and many common risk factors, are
periodontitis and rheumatoid arthritis (RA) [4,5].
While elevated microbial load is an important factor in the
initiation of periodontitis, it is the increase in proportion of specific
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microbial pathogens that is likely to be the crucial factor in the
subsequent progression of this condition [6]. Periodontitis,
particularly in its more severe form, has been linked to a biofilm
that contains a consortium of oral pathogens that includes the
Gram negative anaerobe Porphyromonas gingivalis. [7,8]. P. gingivalis
expresses a peptidylarginine deiminase (PAD) known as PPAD, an
enzyme that modifies peptidylarginine residues to citrulline and is
unique in this regard amongst prokaryotes [9]. PPAD is not
evolutionarily related to the mammalian PADs that catalyse the
same reaction, which is the modification of the guanidino group of
arginine residues to produce peptidyl-citrulline and ammonia.
While citrullination mediated by host PADs is generally consid-
ered a fundamental process (e.g apoptosis), it is also associated with
inflammation in mammals [10].
When investigating potential common causal links between
periodontitis and RA, the ability of P. gingivalis to citrullinate
peptides is noteworthy as auto-antibodies against citrullinated
peptides are highly specific and sensitive in RA diagnosis [11].
Post-translationally modified peptides and proteins containing
citrulline can exhibit altered epitopes compared to those that are
unmodified [12]. Accordingly, citrullination has been reported to
trigger an auto-immune response [11,13] via modified self-proteins
and peptides perceived as foreign by the immune system [14].
While citrullinated peptides may be involved in the pathogenesis of
RA the nature of their role is unclear and the contributions of host
or prokaryote PADs to citrullination is unknown.
It has been proposed that the increased levels of P. gingivalis in
patients suffering from chronic periodontitis might influence the
development of RA, via PPAD promotion of peptide citrullination,
thus explaining the over representation of patients presenting with
periodontitis suffering from RA [15–17].
Therefore the aims of this investigation were to construct a
PAD-deficient P. gingivalis strain and compare the onset and
severity of arthritis and periodontitis in a mouse model in the
presence of either the wild type or PAD-negative strain.
Materials and Methods
Ethics
Approval for the use of BALB/c mice in this study was obtained
from the University of Adelaide, Animal Ethics Committee
(Project Nu M-2012-183R). The animals were housed in the
University of Adelaide PC2 Animal holding facility (OGTR
certification No 2067/2008). Approval to culture and prepare
inoculates of the genetically modified P. gingivalis strain ECR527
was granted by the Institutional Biosafety Committee of the
University of Adelaide (Approval No: IBC Dealing ID 10890).
The animals were assessed daily for a number of general health
parameters including dull/ruffled coat, a change in temperament,
reduced food/water intake or a reluctance to move and body
weight recorded.
Bacterial Strains and Culture Conditions
P. gingivalis strain W50 (wild type) was obtained from the culture
collection of the Oral Health CRC, Melbourne Dental School,
University of Melbourne. A PAD-deficient strain (ECR527) was
derived from W50 for this study. P. gingivalis strains were routinely
maintained on Horse Blood Agar (HBA) plates and antibiotic
selection of 10 mg/mL erythromycin when appropriate. E. coli
alpha-select gold cells (Bioline, London, UK) were grown at 37uC
in Luria Bertani (LB) Broth or maintained on LB agar with
100 mg/mL ampicillin when harbouring pGEM-TEasy plasmids
(Promega, Madison, WI, USA).
DNA Analysis and Manipulations
Oligonucleotide primers used in this study are listed in Table 1.
Genomic DNA from P. gingivalis strains was prepared using the
DNeasy Blood and Tissue kit (Qiagen) and plasmid DNA was
extracted from E. coli using the QIAprep spin miniprep kit
(Qiagen, Venlo, Netherlands). DNA was sequenced by Applied
Genetics Diagnostics, The University of Melbourne.
RT-PCR
RNA was isolated using a NucleoSpin RNA II Total RNA
Isolation kit (Macherey-Nagel, Duren, Germany) and cDNA was
generated using a SuperScrip III Reverse Transcriptase First-
Strand Synthesis SuperMix for qRT-PCR kit with random
hexamers (Life Technologies, California, USA), both according
to the manufacturer’s instructions. BIOTAQ Red DNA Polymer-
ase (Bioline, London, UK) was then used to PCR from the
following templates: 125 ng of cDNA, 125 ng RNA that was not
reverse transcribed, milliQ H2O and 13 ng W50 genomic DNA in
50 mL reactions with gene-specific primer pairs (Table 1) for 30
cycles in a G-Storm GS1 thermal cycler (Gene Works, Adelaide,
Australia). The expected product size from each primer pair was
682 bp for PG1424-RT-Fwd and PG1423-RT-Rev; and 1181 bp
from PG1424-RT-Fwd and PG1422-RT-Rev. DNA was electro-
phoresed at 80 V for 40 min using a 1.0% agarose gel prepared
with tris-acetate buffer (40 mM tris-acetate, 1 mM EDTA, pH 8).
Construction of P. gingivalis PAD-deficient Strain ECR527
The recombination cassette for deletion of the pad gene
consisted of 972 bp upstream of the PG1424 (pad) ORF which
encompassed PG1426, followed by the ermF gene encoding
erythromycin resistance in P. gingivalis, followed by 741 bp
downstream of the PG1424 ORF which encompassed PG1423.
This recombination cassette resulted in replacement of PG1424
with ermF and was constructed from three separate PCR products
that were spliced together using gene splicing by overlap extension
PCRs (SOE PCR) to form the final cassette. SOE PCRs were
performed essentially as previously described [18]. The PCR
products that flanked the PG1424 ORF were amplified from W50
genomic DNA: PG1426 (primers PG1426-Fwd and ErmF-
PG1426-Rev) and PG1423 (primers ErmF-PG1423-Fwd and
PG1423-Rev). The ermF gene was amplified from pVA2198 [19]
with primers PG1426-ErmF-Fwd and PG1423-ErmF-Rev. All
PCRs were performed with Herculase II DNA Polymerase
(Stratagene, La Jolla, Ca, USA) except for the final SOE PCR
which was amplified with Platinum Taq DNA Polymerase High
Fidelity (Life Technologies, California, USA). PCR products were
purified using the NucleoSpin Extract II purification kit
(Macherey Nagel, Duren, Germany) according to manufacturer’s
instructions. The final PCR product was ligated with pGEM-
TEasy and transformed into E. coli alpha-select gold competent
cells (Bioline) by heat shock according to manufacturer’s
instructions. The resulting plasmid was sequenced to confirm the
fidelity of the recombination cassette then it was linearised and
200 ng electroporated into P. gingivalis W50 in a 0.1 cm gap
cuvette at 1.8 kV, 200 Ohms resistance. The resulting PAD-
deficient strain was named ECR527.
Measurement of PAD Activity
A colorimetric microtitre plate assay for the determination of
enzymatic deimination of the substrate N-a-benzoyl-L-arginine
ethyl ester (BAEE) was performed as previously described [20,21].
Briefly, cells from three biological replicate cultures each of P.
gingivalis W50 and ECR527 (OD650 1.1–1.3) were washed and
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resuspended in 0.2 M Tris-HCl (pH 8), 1 mM EDTA, 1 mM flavin
mononucleotide and 10 mM cysteine. A 10 mL aliquot of BAEE
(30 mM) was added to 50 mL cells (16108 cfu) and incubated at
37uC for 30 min before addition of 200 mL of detection reagent.
The detection reagent was assembled daily from its two
components with one part A (0.5% diacetyl monoximine and
0.01% thiosemicarbazide) added to two parts B (0.25 mg of
FeCl3/mL in 24.5% sulphuric acid and 17% phosphoric acid).
The reaction plate was heated at 105uC for 25 min, then cooled
and optically measured at 490 nm using a Bio-Tek Powerwave
Table 1. Oligonucleotide primers used in this study.
Oligonucleotide Primer Sequence (59-39)a Purpose
PG1424-RT-Fwd ATCGAAGCAGATGTCGTCTCAT RT PCR
PG1423-RT-Rev TACGAAACCAATGCTCAGATTTTG RT PCR
PG1422-RT-Rev ATAGTTGGATGCGAGAGAAGGA RT PCR
PG1426-Fwd GAAGCACGTAATAAGGACAATGAC pad recombination cassette
ErmF-PG1426-Rev ACGGGCAATTTCTTTTTTGTCATTGTTTGATATGTTTTATGATGTTATGAA pad recombination cassette
PG1426-ErmF-Fwd TTCATAACATCATAAAACATATCAAACAATGACAAAAAAGAAATTGCCCGT pad recombination cassette
PG1423-ErmF-Rev GTATTCTCAAATAAGGGGCCTTACGAAGGATGAAATTTTTCAGG pad recombination cassette
ErmF-PG1423-Fwd CCTGAAAAATTTCATCCTTCGTAAGGCCCCTTATTTGAGAATAC pad recombination cassette
PG1423-Rev CATCGACGATGATATCTCCTGT pad recombination cassette
aUnderlined sequence of SOE primers indicates the part of the primer that is not complementary to the target sequence, but provides complementarity with a second
PCR product for splicing.
doi:10.1371/journal.pone.0100838.t001
Figure 1. Micro CT appearance and analysis of periodontal bone loss. A. Micro CT of mouse jaw for CMC control group. B. Micro CT of
mouse jaw for ECR527 & EA group. C. Micro CT of mouse jaw W50 & EA group. D. Measurements of bone changes in the jaw were calculated by
measuring the cemento-enamel junction-alveolar bone crest on three slices for each mouse using CTAn sagital sections. Data represent mean (6
SEM). The number of animals in each group was 6 and measurements were performed in triplicate. Statistical analysis was done by one way ANOVA
and Tukey multiple comparisons. White bars represent CEJ/ABC distance measurements. Abbreviations: CMC= carboxymethyl cellulose;
ECR527=PAD-deficient P. gingivalis; W50=wild type P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g001
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spectrophotometer (Biotek Instruments, Winooski, VT, USA). A
standard curve was generated using 0–400 mM L-citrulline using
the same method to quantify citrulline in samples.
Animal Groupings
Thirty six female BALB/c mice between 6 and 8 weeks old were
acquired from the Laboratory Animal Services (LAS) of the
University of Adelaide. Six experimental groups each containing
six mice were used. All groups received oral inoculations for the
duration of the study and three groups in addition to the
inoculations were induced with experimental arthritis (EA) using a
mouse monoclonal antibody against type II collagen (Arthrogen-
CIA Arthritogenic Monoclonal Antibody, Chondrex Inc., Red-
wood, WA, USA).
Group 1: Control: 2% Carboxylmethylcellulose (CMC) (Sigma, St
Louis, MO, USA)
Group 2: PPAD2: PAD-deficient P. gingivalis (ECR527)
Group 3: PPAD+: Wild type P. gingivalis (W50)
Group 4: Control + EA: 2% CMC with induced EA
Group 5: PPAD2 + EA: PAD-deficient P. gingivalis (ECR527) with
induced EA
Group 6: PPAD+ + EA: Wild type P. gingivalis (W50) with induced
EA
Induction of Experimental Periodontitis by Oral
Inoculation
The preparation of the inocula and the inoculation protocol to
induce an experimental periodontitis in female BALB/c mice has
been previously described [22]. All mice were inoculated with
either wild type P. gingivalis (Groups 3 and 6) or PAD-deficient P.
gingivalis (Groups 2 and 5). The control groups (Groups 1 and 4)
Table 2. Recovery of viable P. gingivalis from oral swabs after final inoculation.
Group Recovery 0 hr Recovery 6 hr Recovery 24 hr PPAD activity
Control 2 2 2 2
Wild-type (W50) + + + *
PAD-deficient (ECR527) + + + 2
(+) Viable wild type (W50) and PAD-deficient (ECR527) P. gingivalis strainsW50 and ECR527 were recovered from the gingiva of each group of mice inoculated separately
with each strain at the three time points assayed. The colonies in both groups were black pigmented with gram negative staining organisms.
(2) No viable organisms were recovered from the control group receiving the vehicle (2% CMC).
(*) PPAD activity was only demonstrated in the group of mice where P. gingivalis W50 was recovered from gingival swabs.
doi:10.1371/journal.pone.0100838.t002
Figure 2. Histological analysis of maxillary periodontal tissues. A. Histology of mouse jaw for CMC control group at day 63. B. Histology of
mouse jaw for ECR527 & EA group at day 63. C. Histology of mouse jaw for W50 & EA group at day 63. Arrow indicates increased inflammatory
reaction in supra-crestal alveolar bone gingival tissue. D. Histological scores (mean 6 SEM) for the presence of osteoclasts and evidence of bone
erosion around the first and second upper molars for all groups in the study. Original magnification of A–C= 100X. The number of animals in each
group was 6 and measurements were performed in triplicate. Statistical analysis was done by one way ANOVA and Tukey multiple comparisons.
Abbreviations: CMC= carboxymethyl cellulose; ECR527=PAD-deficient P. gingivalis; W50=wild type P. Gingivalis; EA = experimental arthritis.
doi:10.1371/journal.pone.0100838.g002
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were inoculated with the suspension vehicle for P. gingivalis strains,
2% CMC. PPAD activity for both strains was assessed prior to the
preparation of each inoculum using the colorimetric method
described above. Animals were inoculated over two intensive
sequences, each comprising four inoculations over an eight day
period. The first sequence commenced two days after the mice had
completed 7 days of antibiotic treatment of 1 mg/mL kanamycin
(Sigma, St. Louis, MO, USA) in deionised water ad libitum. The
inoculation sequences were separated by a period of two weeks
and during this period mice were inoculated twice a week.
Following the second intensive inoculation sequence all mice
continued to be inoculated twice a week for the remainder of the
experimental period. All animal inoculations were performed by
experienced professional staff within a Class II Biological safety
cabinet and PC2 animal holding facility.
Induction of Collagen Antibody-induced Arthritis -
Experimental Arthritis
Experimental arthritis (EA) was induced in Groups 4–6 by
intravenous tail vein injection with 1.5 mg of a mouse monoclonal
antibody against type II collagen (Arthrogen-CIA Arthritogenic
Monoclonal Antibody, Chondrex Inc., Redwood, WA, USA).
This procedure was performed two days after completion of the
second intensive inoculation sequence (day 44). To aid in the
induction of EA a dose of 5 mg of lipopolysaccharide (LPS) was
intraperitoneally administered three days after the antibody
exposure, as described previously [23].
Visual Scoring of Paw Swelling
Front and rear paws were visually assessed and scored each day
by two experienced observers to assess swelling and inflammation.
Two different scales were used to assess paw changes throughout
the experiment. Firstly each inflamed toe or knuckle received a
score of 1 and a fully inflamed swollen wrist/ankle a score of 5.
Each assessed paw received a score between 0–15 and the total
score per mouse was 0–60 [24]. The second system employed a
scoring system whereby each paw was allocated a score from zero
to four according to the level of inflammation and swelling to make
a total score of 16 for each animal. 0 = normal paw, 1 = mild but
definite redness and swelling of the wrist/ankle, 2 = moderate
swelling and redness of the wrist/ankle with digit involvement,
3 = severe swelling and redness of the paw with digit involvement
and 4 = maximum inflammation the entire paw, with multiple
digit involvement.
Figure 3. Micro CT appearance and analysis of bone erosion in front paw radio-carpal joint. A. Micro CT appearance of paw for CMC
control group at day 63. B. Micro CT appearance of paw for ECR527 & EA group at day 63. C. Micro CT appearance of paw for W50 & EA group at day
63. D. The front paws (left and right combined), were processed to determine bone loss/growth between the two scanned time points in the radio-
carpal joint. Data represent mean (6 SEM). The number of animals in each group was 6 and measurements were performed in duplicate. Statistical
analysis was done by one way ANOVA and Bonferroni multiple comparisons. Abbreviations: CMC= carboxymethyl cellulose; ECR527=PAD-deficient P.
gingivalis; W50=wild type P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g003
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Live Animal Micro-computed Tomography
Mice were scanned using the Skyscan 1076 High Resolution live
animal computed tomography (micro CT) (SkyScan, Bruker,
Belgium) to determine changes in bone volume in the radio-carpal
joint and cemento-enamel junction to the alveolar bone crest
(CEJ-ABC) length in the jaws. The scanning width was set to
35 mm with a resolution of 9 mm. Detailed specifications for micro
CT imaging have previously been published [22]. Animals were
anaesthetised prior to scanning with a mixture of ketamine and
xylazine and positioned on a polystyrene foam holder then placed
within an enclosed container with a HEPA filter at the ends. The
container was placed in the 3 cm carbon fibre bed of the micro
CT scanner. Mice were scanned before the induction of
experimental inflammatory disease to obtain baseline measure-
ments and again at the completion of the study (10 days post
experimental arthritis induction).
Micro-CT Data Processing
Scans were reconstructed using Skyscan NRECON software
(Version 1.6.6.0). Settings used; smoothing = 1, ring artefact = 15,
beam hardening = 30% and misalignment compensation was
adjusted manually using the DataViewer program (Skyscan,
Bruker, Belgium). The BMP files created were opened in CT
Analyser (Version 1.12.0.0+) to create a volume of interest. To
realign images and save the appropriate plane for either the radio-
carpal joint or determining the CEJ-ABC distance, DataViewer
(Version 1.4.4 64-bit) was used. Transaxial images were saved for
the bone volume determinations in the radio-carpal joint, and
sagittal images for the CEJ-ABC distance. The images were then
opened in CTAnalyser to measure bone volume or CEJ-ABC
distance. The histogram settings were set at 100 and 255 to
measure both the bone volume in the radio-carpal joint and CEJ-
ABC junction distance. The bone volume was calculated in a set
number (200) 9 mm slices above and below a standard reference
point set within the radiocarpal joint. The CEJ-ABC distance was
measured between the second and third molars on three slices for
each mouse [22,25].
Serum Collection
Approximately 100 mL of blood was collected from cheek
puncture bleeds at the commencement of the study (Time = 0) and
at 6 weeks. Cardiac puncture was used at the conclusion of the
study (week 9). Blood was allowed to clot for 1 hour at room
temperature, centrifuged at 1000 g for 20 min at room temper-
ature and the serum removed and dispensed into aliquots and
stored prior to analysis at 280uC.
ELISA Assays
An anti-CCP kit (AXIS-Shield, Dundee, Scotland) was modified
and used to assess levels of anti-CCP antibodies in mouse sera.
Week 9 serum was diluted 1:200 and analysed according to the
manufacturer’s instructions by substitution of an anti-mouse
horseradish peroxidase-conjugated secondary to detect mouse
IgG (Cell Signalling Technology, Boston, MA, USA).
Antibodies to wild type P. gingivalis were detected by coating
Costar Maxisorp 96 well plates (Corning, Tewksbury, MA, USA)
with 16108 formalin fixed cells in 50 mM bicarbonate buffer, pH
9.4, overnight at 4uC. Wells were washed 3 times in PBS/0.05%
Tween-20 (PBS-T) and blocked with 5% skim milk in PBS-T for
1 hr at room temperature followed by three washes of PBS-T. An
antibody against P. gingivalis purchased from the Developmental
Studies Hybridoma Bank (Iowa City, IA, USA) was used as a
control and to produce a standard curve. Mouse serum samples
from time (day 0, 6 weeks and 9 weeks) were diluted 1:100, added
to wells in duplicate and incubated at room temperature for 2 hrs.
Wells were washed three times and incubated with a mouse
horseradish peroxidase-conjugated secondary antibody (1:10000)
(Cell Signalling Technology, Boston, MA, USA) for 45 minutes at
room temperature. After the final washes the substrate reagent was
prepared (R&D, Minneapolis, MN, USA) and added to wells. The
colour reaction was stopped with 2 M H2SO4 and the plate read
at 450 nm on the Power-wave plate reader using dedicated KC4
microplate data analysis software (Biotek Instruments, Winooski,
VT, USA).
Histological Evaluation
At the conclusion of the study (day 63) mice were euthanized by
CO2 inhalation. All paws and heads were retrieved from each
mouse and placed into 10% buffered formalin for two days.
Following fixation, the specimens were rinsed thoroughly in
Figure 4. Visual appearance and scoring of paw swelling. A.
Appearance of front and rear paws for CMC control group at day 7 post
EA induction. B. Appearance of front and rear paws for ECR527 & EA
group at day 7 post EA induction. C. Appearance of front and rear paws
for W50 & EA group at day 7 post EA induction. D. Total paw score
grade out of a 60 including front and back paws. Data represent mean
(6 SEM). The number of animals in each group was 6 and
measurements were performed once daily per animal Statistical analysis
was done by two way ANOVA and Tukey multiple comparisons. Raw
data for data points are shown in Figure S1. Abbreviations: CMC= car-
boxymethyl cellulose; ECR527=PAD-deficient P. gingivalis; W50=wild
type P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g004
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physiological buffered saline (PBS) and then decalcified in 10%
EDTA for 14 days with regular replacement of the solution over
this period. Complete decalcification was confirmed by digital
radiography and specimens paraffin embedded and sectioned at a
thickness of 7 mm. Sections were stained with haematoxylin and
eosin for histological analysis. Slides were viewed using a Leica
DM1000 microscope and imaged with a connected Leica DFC450
Camera system (Leica Microsystems, Wetzlar, Germany). The
front and rear paws were assessed for inflammatory changes, bone
and cartilage destruction and pannus formation. A point scale (0–
3) was used to score the severity of inflammatory changes based on
the number and type of inflammatory cells, (0 = normal tissue, 0–
5% inflammatory cells; 1 = mild inflammation 5–25% inflamma-
tory cells; 2 = moderate inflammation 25–50% inflammatory cells;
3 = severe inflammation .50% inflammatory cells). Bone and
cartilage destruction was assessed in a similar fashion (0 = normal,
1 = mild cartilage destruction, 2 = evidence of bone and cartilage
destruction, 3 = severe bone and cartilage destruction. Pannus
formation in the joint was also noted. The periodontium of the
maxillary molars was assessed for inflammation with interdental
papilla reduction, and presence of osteoclasts with bone erosion
particularly between the first and second molars. The severity of
each parameter was scored separately on a scale from 0 to 3
(0 = normal, 1 = mild effect, 2 = moderate effect, 3 = severe effect).
The sections assessed and selected for each mouse were all at the
level where the distal root of the first molar and proximal root of
the second molar was clearly visible [23].
Figure 5. Histological assessment of joint inflammation. A. Histology of the radio-carpal joint for CMC control group at day 63. B. Histology of
the radio-carpal joint for ECR527 & EA group at day 63. C. Histology of the radio-carpal joint for W50 & EA group at day 63. Arows indicate increased
inflamaotry reaction in joint. D. Histological scores (mean 6 SEM) for (a) inflammation and (b) bone and cartilage destruction for both front and rear
paws combined. Original magnification of A–C=100X. The number of animals in each group was 6 and measurements were performed in triplicate.
Statistical analysis was done by One way ANOVA and Bonferroni multiple comparisons. Abbreviations: CMC= carboxymethyl cellulose; ECR527=PAD-
deficient P. gingivalis; W50=wild type P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g005
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Recovery of P. gingivalis from the Oral Cavity
Three groups of six mice were inoculated with either 2% CMC
(vehicle control), wild type P. gingivalis or PAD-deficient P. gingivalis.
The inoculation sequence employed was identical to that of
Groups 1–3 described previously. At 0, 6 and 24 hrs after the final
inoculation sequence the animals gingivae were swabbed using
periodontal strips and these were used to inoculate Brain Heart
Infusion Broth. Broth cultures were gown under anaerobic
conditions for seven days and an inoculum from each culture
spread onto anaerobic blood agar plates. Following seven days of
anaerobic incubation a typical black-pigmented colony from each
group was Gram stained and assayed for PPAD activity.
Statistical Analysis
The data collected from all surviving mice in this study was
analysed by one-way ANOVA. When the global test was
statistically significant (p,0.05), post hoc comparisons were
performed using the Tukey or Bonferroni’s Multiple Comparison,
95% confidence level. Unpaired t-tests were also used for 2 group
comparisons. All testing was carried out with Graph Pad Prism 6
as the statistical analysis package. Significance levels were set at
p,0.05 for all tests.
Results
Construction of PAD-deficient P. gingivalis Strain
(ECR527)
Peptidylarginine deiminase is encoded on the wild type P.
gingivalis genome at locus PG1424. It is predicted by Microbe-
sOnline [26] to be the first gene in a 3 gene operon with PG1423
and PG1422, which we have confirmed in P. gingivalis W50 using
reverse transcription PCR. The RT-PCR products corresponded
to the predicted sizes of 682 bp for the primer pair specific for
PG1424/PG1423 and 1181 bp for the primer pair specific for
PG1424/PG1422 (data not shown). A recombination cassette was
constructed using gene splicing by Overlap Extension PCRs where
the open reading frame of the ermF gene, which confers
erythromycin resistance was inserted in place of the PG1424
ORF, so that ermF would be expressed from the PG1424
promoter. Replacement of the PG1424 ORF with the ermF
ORF was successfully achieved in P. gingivalis strain W50 with the
resulting mutant (ECR527) noticeably slower to pigment than wild
type W50. Loss of PPAD activity by the PAD-deficient P. gingivalis
Figure 6. Serum anti-CCP antibody levels. The mean (6 SEM) titre
of anti-CCP antibodies detected in the sera of mice at week 9 from each
of the 6 treatment groups. Raw data for data points are shown in Figure
S2. The number in each group was 6 and measurements were
performed in duplicate. Statistical analysis was done by one way
ANOVA and Tukey multiple comparisons. Abbreviations: CMC= carbox-
ymethyl cellulose; ECR527= PAD-deficient P. gingivalis; W50=wild type
P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g006
Figure 7. Serum anti-P. gingivalis levels. The mean (6 SEM) titre of anti-P.gingivalis detected in the sera of mice over 9 week time course. Raw
data for data points are shown in Figure S3. The number in each group was 6 and measurements were performed in duplicate. Statistical analysis was
done by one way ANOVA and Tukey multiple comparisons. Abbreviations: CMC= carboxymethyl cellulose; ECR527= PAD-deficient P. gingivalis;
W50=wild type P. Gingivalis; EA = experimental arthritis
doi:10.1371/journal.pone.0100838.g007
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was confirmed biologically by loss of the ability of ECR527
cultures to deiminate the substrate BAEE whereas 16108 cfu of
wild type P. gingivalis produced 20.460.8 nmol N-a-benzoylcitrul-
line ethyl ester in 30 min from 300 nmol BAEE.
Post Inoculation Recovery of P. gingivalis from Gingiva
Following incubation, black-pigmented colonies of Gram
negative bacteria were observed on blood agar plates from the
swabs obtained at 0, 6 and 24 hours post final inoculation with
wild type P. gingivalis W50 and PAD-deficient P. gingivalis. However
no growth was observed from swabs of animals inoculated with
2% CMC vehicle control. PPAD activity was positive only for
bacteria recovered from animals exposed to W50 (Table 2).
Micro-CT Analysis of Periodontal Bone Loss
To determine the effect of PPAD on the periodontium, bone
loss in the jaws of the mice, the cemento-enamel junction to
alveolar bone crest (CEJ-ABC) length was measured in all 6 groups
(Figure 1). No significant difference between PAD-deficient P.
gingivalis and the CMC vehicle control was observed. However a
significant increase in CEJ-ABC distance reflecting increased bone
loss was observed between wild type P. gingivalis and CMC vehicle
control (p = 0.01) and wild type P. gingivalis with experimental
arthritis and CMC vehicle control with experimental arthritis
(p = 0.001). Furthermore, there was significantly higher bone loss
between wild type P. gingivalis W50 and PAD-deficient P. gingivalis
(p = 0.04) over wild type P. gingivalis with experimental arthritis and
PAD-deficient P. gingivalis with experimental arthritis (p = 0.005).
Histological Analysis of Maxillary Periodontal Tissues
Histological assessment of the periodontal tissue around the first
and second maxillary molars demonstrated a statistically signifi-
cant number of osteoclasts and evidence of bone resorption in the
experimental arthritis groups where the difference between the
PAD-deficient P. gingivalis and the CMC groups were also
significantly different to the wild type P. gingivalis group (p = 0.03
and p = 0.02 respectively; Figure 2). There was no statistical
difference seen between the non-experimental arthritis groups and
the experimental arthritis group which had CMC or PAD-
deficient P. gingivalis inoculations. Interestingly, the control group
with induced experimental arthritis showed evidence of bone
resorption which was not seen in the CMC group where there was
no induced experimental arthritis.
Micro-CT Analysis of Bone Erosion in Front Paw Radio-
carpal Joint
Animals were micro-CTscanned and the radio-carpal joints of
both paws (combined) were analysed for changes in bone volume
over time. The W50 group with EA showed significantly lower
bone volume change reflecting increased bone loss, than the CMC
with experimental arthritis group in the radio-carpal joint (p,
0.04) (Figure 3). Other group comparisons were not significant.
Visual Scoring of Paw Swelling
Front and rear paws of all mice induced with experimental
arthritis were scored daily for swelling and inflammation. There
was no significant difference between the control (CMC inoculated
group) and the group inoculated with PAD-deficient P. gingivalis for
the onset of disease and maximum paw score at the height of the
disease (day 6–7). However this was not the case for the group that
received wild type P. gingivalis. There was a rapid onset with
swelling and inflammation evident at day 4 and continued for the
next 3 days with paw scores significantly higher (p,0.0001) than
those of the CMC and PAD-deficient P. gingivalis groups (Figure 4).
Histological Assessment of Joint Inflammation
Histological assessment of the sections of inflamed paws in the
experimental arthritis group of animals confirmed the observations
from the clinical paw scores that the level of inflammation and
cartilage and bone destruction was significantly higher in the
group inoculated with wild type control groups (p = 0.02 and 0.01
respectively). A significant difference was also noted between the
wild type P. gingivalis and PAD-deficient strain for inflammation
and bone/cartilage destruction (p = 0.02 and p = 0.009 respec-
tively). No differences were observed between the PAD-deficient
strain and the CMC control groups (Figure 5). There was no paw
inflammation observed in groups that did not undergo experi-
mental arthritis induction.
Serum anti-CCP Antibody Levels
Control mice (inoculated with CMC) demonstrated a back-
ground level of anti-CCP antibodies (ACPA). Similar levels were
demonstrated in the groups inoculated with wild type P. gingivalis
and PAD-deficient P. gingivalis strains. There was no significant
increases in anti-CCP titre in the CMC and P. gingivalis ECR527
inoculated groups compared to the groups with no EA. Only mice
induced with EA and with pre-existing periodontitis induced by P.
gingivalis W50 demonstrated a trend towards an increase in anti-
CCP antibodies, but this was not significant (Figure 6).
Serum anti-P. gingivalis Levels
Mice developed antibodies to P. gingivalis over the course of the
experiment. Antibody titres increased significantly following
induction of experimental arthritis at week 9 in all groups.
However those inoculated with wild type P. gingivalis produced a
higher titre than experimental arthritis alone (p = 0.001) and
experimental arthritis plus PAD-deficient P. gingivalis. (p = 0.02)
(Figure 7)
Discussion
Of the many hypotheses proposed for a linking mechanism
between periodontal disease and RA, the role of citrullination and
production of anti-cyclic citrullinated antibodies is of particular
interest [15,27]. Citrullination is a common post-translational
modification based on the conversion of arginine into citrulline. It
occurs frequently in various tissues of the body, particularly at sites
of inflammation, and is initiated by peptidylarginine deiminases
(PADs). A key concept in the pathogenesis of RA is the preclinical
phase which precedes the clinical manifestation of RA [28]. This
concept is predicated on the identification of serum autoantibodies
years before the development of RA. Indeed there is good
evidence to suggest that the immunological conflict often predates
the onset of RA by several years. A key component in this process
is the production of anti-citrullinated protein antibodies [10]. The
production of citrullinated proteins and anti-citrullinated protein
antibodies at extra-articular sites prior to the development of RA is
well documented [10]. It has been proposed that the inflamed
periodontal tissues may be one such site [29].
A number of animal models of experimental arthritis have been
studied, each presenting certain advantages and disadvantages
[30]. The model chosen for this study, collagen antibody induced
arthritis, is characterized by macrophage and polymorphonuclear
leukocyte infiltrate within the joints. In this model the anti-
collagen antibody is adoptively transferred and therefore it does
not rely on specific B- and T-cell responses for disease to ensue.
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Nonetheless the development of arthritis in the CAIA model is
similar to other models with regards to the inflammatory cytokine
response and pannus formation within the affected joints [31,32].
While the role of anti-citrullinated protein antibodies in the
pathogenesis of rheumatoid arthritis has been controversial, there
is good evidence to support a pathogenic role for these antibodies
in the development of both experimental arthritis and human
rheumatoid arthritis. [33,34]. While not studied in as much detail
as other experimental arthritis models, anti-citrullinated protein
antibodies have been suggested to play a role in the severity of
disease in the collagen antibody induced arthritis model of
experimental arthritis [35,36]. To date there have been no reports
concerning an anti-citrullinated protein antibody response in
experimental periodontitis. In this regard the present study is
significant since it reports that mice with experimental periodon-
titis and subsequent induction of experimental arthritis demon-
strated a trend (not significant) towards an increase in anti-
citrullinated protein antibody titre. The precise role that anti-
citrullinated protein antibodies play in this process await further
investigation.
Shortly after P. gingivalis was shown to be the only prokaryote to
produce a peptidylarginine deiminase (PPAD) a hypothesis was
presented in which the ability of this organism to citrullinate
proteins through secretion of PPAD could be one mechanism
whereby anti-citrullinated protein antibodies could develop and
result in an exaggerated antibody response with subsequent joint
inflammation and development of rheumatoid arthritis [9,15].
To explore this concept further we constructed a knock-out P.
gingivalis strain deficient in PPAD expression (ECR527) with view
to examining the role of PPAD in the development of both
experimental periodontitis and arthritis. We have recently
completed sequencing of the PAD-deficient P. gingivalis on our
in-house ion torrent and found no secondary mutations, indicating
that the experimental results were solely due to the deletion of pad
from P. gingivalis (unpublished data).
There is only one other report in the literature that has used a
PAD-deficient P. gingivalis strain in a experimental arthritis model
[37]. However, our study complements and extends this earlier
study [37] by investigating experimental periodontitis in addition
to experimental arthritis and a combination of both. This is an
important extension of the earlier study [37] which investigated
the effect of subcutaneous inoculation of P. gingivalis on experi-
mental arthritis only. Furthermore we demonstrated that both the
wild type and PAD-deficient strain of P. gingivalis survived in the
oral cavity after oral inoculation. Recent observations indicate that
experimental periodontitis can only progress in the presence of a
biofilm containing viable P. gingivalis [38]. In this study we used P.
gingivalis W50 as it is highly virulent in murine periodontitis models
[39–45].
With regards to the induction of experimental periodontitis it
was noteworthy that oral inoculation with the PAD-deficient strain
resulted in a significantly reduced amount of periodontal bone loss
compared to oral inoculation with the wild type P. gingivalis. The
reasons for this response are as yet unclear and require further
investigation but this finding does implicate a role for PAD in the
pathogenesis of periodontitis.
When periodontitis was first induced followed by induction of
experimental arthritis studies it was noted that inoculation with the
PAD-deficient P. gingivalis strain resulted in reduced severity and
onset of arthritis. This is in agreement with a previous study in
which it was noted that inoculation with PAD-deficient strain of P.
gingivalis resulted in reduced severity of collagen-induced experi-
mental arthritis [37].
In recent years the concepts of molecular mimicry and
posttranslational modification of proteins in auto-immune reac-
tions such as RA have been actively debated [28,46]. Interestingly,
P. gingivalis appears as a likely agent involved in these processes.
For example, cross reactivity of antibodies to P. gingivalis heat shock
protein (HSP 60) and host-derived heat shock protein in the
pathogenesis of RA has been documented [47]. Another case for
molecular mimicry involving P. gingivalis has been made whereby
antibodies against citrullinated human a-enolase cross react with
citrullinated P. gingivalis enolase [27]. Similarly, the ability of P.
gingivalis to produce PPAD which can citrullinate host proteins and
lead to an early anti-citrullinated protein antibody response has
also implicated this bacterium in the pathogenesis of RA [37].
While antibodies to PPAD have been detected in the sera of mice
injected with P. gingivalis, the titre is very low and this reaction
probably does not contribute to the process of P. gingivalis-induced
exacerbation of experimental arthritis [37]. In the present study,
when periodontitis was induced the anti-citrullinated protein
antibody serum levels for control and PAD-deficient strains were
similar. However, following induction of experimental arthritis the
anti-citrullinated protein antibody titres were elevated only for the
wild type strain and not for the controls or PAD-deficient strains.
This implies a synergistic role for PPAD in the development of
experimental arthritis. This observation is in line with those from a
study using a different model of collagen-induced experimental
arthritis [37].
The emerging data now significantly implicate local citrullina-
tion within inflamed periodontal tissues as having the potential to
be an extra-articular source of citrullination and production of
anti-citrullinated protein antibodies. To date, smoking has been
considered a major risk factor in the pathogenesis of RA whereby
smoking leads to citrullination within the lung and a priming anti-
citrullinated protein antibody response which leads to exacerba-
tion of the anti-citrullinated protein antibody response and
associated tissue destruction within inflamed joints. In light of
recent observations of the presence of inflammation-associated
citrullination, presence of PAD-2 and PAD-4 in gingival tissues
[28,48] as well as PPAD in serum [49] now provides good
evidence for another important extra-articular source for citrulli-
nation and anti-citrullinated protein antibody production to occur
years in advance of the development of the clinical signs and
symptoms of RA. In this regard it is significant that individuals
with untreated RA who are non-smokers but presenting with
chronic periodontitis have a significantly high level of anti-
citrullinated protein antibody titres [50].
In conclusion this study has demonstrated that PPAD appears to
be a significant factor in the development of experimental
periodontitis and exacerbation of experimental arthritis. Interpre-
tation of these findings must be made in the context that the
animal models used do not completely reflect the complexities of
human dises for both periodontitis and rheumatoid arthrits.
Nonetheless these findings adds further evidence for a potentail
role of P. gingivalis in the pathogenesis and exacerbation of arthritis.
Further studies are now needed to elucidate the mechanisms
which drive these processes.
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